XT
SNTI icon

XTX Topco’s Senti Biosciences Holdings SNTI Stock Holding History

XTX Topco’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26K Buy
23,610
+6,333
+37% +$6.2K ﹤0.01% 3858
2026
Q1 		$14K Buy
+17,277
New +$16.7K ﹤0.01% 3626
2025
Q4 		– Sell
-26,567
Closed -$37.5K – 3762
2025
Q3 		$37.5K Buy
+26,567
New +$44.4K ﹤0.01% 2223
2024
Q1 		– Sell
-2,165
Closed -$14.3K – 2291
2023
Q4 		$14.3K Buy
+2,165
New +$8.44K ﹤0.01% 1397

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
MVM
Menlo Ventures Management Menlo Park, California $357M AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

XTX Topco's SNTI Position: Q2 2026 in Review

XTX Topco increased its Senti Biosciences Holdings (SNTI) stake by 37% in Q2 2026, buying an estimated $6.2K and bringing the position to 23,610 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3858.

XTX Topco first reported a position in SNTI in Q4 2023 and has held it in 4 quarters since. The position peaked at $37.5K in Q3 2025. 19 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

  • XTX Topco held 23,610 shares of Senti Biosciences Holdings worth $26K as of Q2 2026.
  • XTX Topco bought 6,333 Senti Biosciences Holdings shares in Q2 2026, an estimated $6.2K.
  • Senti Biosciences Holdings made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3858 holding.
  • XTX Topco first reported a position in Senti Biosciences Holdings in Q4 2023 and has held it in 4 quarters since.
  • XTX Topco's Senti Biosciences Holdings position peaked at $37.5K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.